Cargando...
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody-Drug Conjugates (ADCs) are a class of cancer therapeutics that combines antigen specificity and potent cytotoxicity in a single molecule as they are comprised of an engineered antibody linked chemically to a cytotoxic drug. Four ADCs have received approval by the Food and Drug Administratio...
Guardado en:
| Publicado en: | J Exp Clin Cancer Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802061/ https://ncbi.nlm.nih.gov/pubmed/29409507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0667-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|